Hydrochloride, Propoxycaine,
Propoxycaine,
Propoxycaine Hydrochloride,
Propoxyprocaine,
Propoxycaine hydrochloride,
550-83-4,
Ravocaine hydrochloride,
Propoxycaine HCl,
Propoxycaine (hydrochloride),
Pravocaine hydrochloride,
UNII-K490D39G46,
WIN 3459,
EINECS 208-988-7,
Propoxycaine hydrochloride [USP],
K490D39G46,
2-(Diethylamino)ethyl 4-amino-2-propoxybenzoate monohydrochloride,
4-Amino-2-propoxybenzoic acid 2-(diethylamino)ethyl ester hydrochloride,
Propoxycaine hydrochloride (USP),
BENZOIC ACID, 4-AMINO-2-PROPOXY-, 2-(DIETHYLAMINO)ETHYL ESTER, MONOHYDROCHLORIDE,
C16H26N2O3,
NCGC00016505-01,
CAS-550-83-4,
2-(diethylamino)ethyl 4-amino-2-propoxybenzoate;hydrochloride,
Blockain Hydrochloride,
AC1L1WKH,
CHEMBL1769,
DSSTox_CID_25325,
DSSTox_RID_80804,
DSSTox_GSID_45325,
SCHEMBL24720,
Blockaine hydrochloride (TN),
MLS002154133,
DTXSID6045325,
2-diethylaminoethyl 4-amino-2-propoxybenzoate hydrochloride,
HMS1571C20,
Pharmakon1600-01505572,
HY-B1243,
Tox21_110462,
NSC760044,
AKOS030526159,
API0009273,
CCG-213485,
CS-4955,
NSC-760044,
LS-36011,
SMR001233440,
PROPOXYCAINE HYDROCHLORIDE (200 MG),
D02099,
SR-01000841224,
SR-01000841224-2,
Blockain,
Darvon,
Dolene,
Kesso-Gesic,
Propoxyphene HCl,
Prophene 65,
Propoxyphene HCl 65,
C16H26N2O3.ClH,
CID11078,
C16-H26-N2-O3.Cl-H,
RAVOCAINE AND NOVOCAIN W/ LEVOPHED,
RAVOCAINE AND NOVOCAIN W/ NEO-COBEFRIN,
4-Amino-2-propoxybenzoic acid 2-diethylaminoethyl ester hydrochloride,